Sumitomo Dainippon Pharma America
GPTKB entity
Statements (12)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:focusesOn |
neuroscience
oncology rare diseases |
| gptkbp:headquartersLocation |
gptkb:Cambridge,_Massachusetts
|
| https://www.w3.org/2000/01/rdf-schema#label |
Sumitomo Dainippon Pharma America
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:parentCompany |
gptkb:Sumitomo_Dainippon_Pharma
|
| gptkbp:subsidiary |
gptkb:Sumitomo_Dainippon_Pharma_Co.,_Ltd.
|
| gptkbp:bfsParent |
gptkb:Sumitomo_Pharma_America
|
| gptkbp:bfsLayer |
7
|